Fedor Denkers

1.4k total citations
28 papers, 1.0k citations indexed

About

Fedor Denkers is a scholar working on Molecular Biology, Hematology and Cancer Research. According to data from OpenAlex, Fedor Denkers has authored 28 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 15 papers in Hematology and 9 papers in Cancer Research. Recurrent topics in Fedor Denkers's work include Acute Myeloid Leukemia Research (14 papers), Protein Degradation and Inhibitors (5 papers) and Head and Neck Cancer Studies (5 papers). Fedor Denkers is often cited by papers focused on Acute Myeloid Leukemia Research (14 papers), Protein Degradation and Inhibitors (5 papers) and Head and Neck Cancer Studies (5 papers). Fedor Denkers collaborates with scholars based in Netherlands, United States and Austria. Fedor Denkers's co-authors include Ruud H. Brakenhoff, Michiel W. M. van den Brekel, J. Alain Kummer, Linda Smit, Gert J. Ossenkoppele, Gerrit Jan Schuurhuis, Chris J.L.M. Meijer, Viola M. M. van Houten, Peter J.F. Snijders and Ludi E. Smeele and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Fedor Denkers

28 papers receiving 999 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fedor Denkers Netherlands 17 523 353 302 225 175 28 1.0k
Serge Smeets Netherlands 17 541 1.0× 751 2.1× 400 1.3× 306 1.4× 26 0.1× 39 1.4k
R Lilleng Norway 12 252 0.5× 374 1.1× 420 1.4× 199 0.9× 24 0.1× 17 952
Saman Abbas Netherlands 8 676 1.3× 121 0.3× 142 0.5× 242 1.1× 619 3.5× 10 1.1k
Saara Kantola Finland 10 220 0.4× 357 1.0× 372 1.2× 243 1.1× 19 0.1× 14 835
Qiuliang Wu China 16 407 0.8× 131 0.4× 446 1.5× 275 1.2× 41 0.2× 37 922
K.R. Nalinakumari India 16 439 0.8× 195 0.6× 276 0.9× 157 0.7× 19 0.1× 25 788
Andre L. Reed United States 8 613 1.2× 262 0.7× 505 1.7× 186 0.8× 10 0.1× 11 1.0k
H Steininger Germany 18 230 0.4× 108 0.3× 208 0.7× 69 0.3× 68 0.4× 37 887
Nilva K. Cervigne Brazil 16 730 1.4× 94 0.3× 211 0.7× 560 2.5× 22 0.1× 26 1.1k
Jarrard Goodwin United States 4 311 0.6× 250 0.7× 377 1.2× 188 0.8× 13 0.1× 7 655

Countries citing papers authored by Fedor Denkers

Since Specialization
Citations

This map shows the geographic impact of Fedor Denkers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fedor Denkers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fedor Denkers more than expected).

Fields of papers citing papers by Fedor Denkers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fedor Denkers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fedor Denkers. The network helps show where Fedor Denkers may publish in the future.

Co-authorship network of co-authors of Fedor Denkers

This figure shows the co-authorship network connecting the top 25 collaborators of Fedor Denkers. A scholar is included among the top collaborators of Fedor Denkers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fedor Denkers. Fedor Denkers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gils, Noortje van, Michaël Broux, Fedor Denkers, et al.. (2022). Targeting histone methylation to reprogram the transcriptional state that drives survival of drug-tolerant myeloid leukemia persisters. iScience. 25(9). 105013–105013. 8 indexed citations
2.
Gils, Noortje van, Fedor Denkers, & Linda Smit. (2021). Escape From Treatment; the Different Faces of Leukemic Stem Cells and Therapy Resistance in Acute Myeloid Leukemia. Frontiers in Oncology. 11. 659253–659253. 58 indexed citations
3.
Gils, Noortje van, et al.. (2019). PS967 PRECLINICAL ACTIVITY OF THE NOVEL ORAL DUAL BET‐CBP/P300 INHIBITORS, NEO1132 AND NEO2734, IN ACUTE MYELOID LEUKEMIA. HemaSphere. 3(S1). 435–436. 2 indexed citations
4.
Gils, Noortje van, Anna van Rhenen, Fedor Denkers, et al.. (2018). IGFBP7 Induces Differentiation and Loss of Survival of Human Acute Myeloid Leukemia Stem Cells without Affecting Normal Hematopoiesis. Cell Reports. 25(11). 3021–3035.e5. 16 indexed citations
5.
Smit, Marjon A., Fedor Denkers, Monique Terwijn, et al.. (2015). Abstract 2339: IGFBP7 eradicates leukemic stem and progenitor cells in acute myeloid leukemia. Cancer Research. 75(15_Supplement). 2339–2339. 2 indexed citations
6.
Leeuw, David C. de, Fedor Denkers, Walter Pouwels, et al.. (2014). Attenuation of microRNA-126 Expression That Drives CD34+38− Stem/Progenitor Cells in Acute Myeloid Leukemia Leads to Tumor Eradication. Cancer Research. 74(7). 2094–2105. 76 indexed citations
7.
Leeuw, David C. de, Willemijn van den Ancker, Fedor Denkers, et al.. (2013). MicroRNA Profiling Can Classify Acute Leukemias of Ambiguous Lineage as Either Acute Myeloid Leukemia or Acute Lymphoid Leukemia. Clinical Cancer Research. 19(8). 2187–2196. 30 indexed citations
8.
Hess, Corine J., N Feller, Fedor Denkers, et al.. (2008). Correlation of minimal residual disease cell frequency with molecular genotype in patients with acute myeloid leukemia. Haematologica. 94(1). 46–53. 12 indexed citations
9.
Hess, Corine J., Abdellatif Errami, Johannes Berkhof, et al.. (2008). Concurrent methylation of promoters from tumor associated genes predicts outcome in acute myeloid leukemia. Leukemia & lymphoma. 49(6). 1132–1141. 35 indexed citations
10.
Houtenbos, Ilse, Saskia J. Santegoets, Theresia M. Westers, et al.. (2008). The novel bispecific diabody αCD40/αCD28 strengthens leukaemic dendritic cell‐induced T‐cell reactivity. British Journal of Haematology. 142(2). 273–283. 5 indexed citations
11.
Hess, Corine J., Najim Ameziane, Gerrit Jan Schuurhuis, et al.. (2008). Hypermethylation of the FANCC and FANCL promoter regions in sporadic acute leukaemia.. SHILAP Revista de lepidopterología. 30(4). 299–306. 30 indexed citations
12.
Cillessen, Saskia A.G.M., Corine J. Hess, Erik Hooijberg, et al.. (2007). Inhibition of the Intrinsic Apoptosis Pathway Downstream of Caspase-9 Activation Causes Chemotherapy Resistance in Diffuse Large B-Cell Lymphoma. Clinical Cancer Research. 13(23). 7012–7021. 19 indexed citations
13.
Hess, Corine J., Johannes Berkhof, Fedor Denkers, et al.. (2006). Methylation of ESR1 and Tumour Suppressor Genes Together Constitute an Independent Outcome Predictor in Acute Myeloid Leukemia.. Blood. 108(11). 803–803. 4 indexed citations
14.
Hess, Corine J., Fedor Denkers, G.J. Ossenkoppele, et al.. (2004). Gene expression profiling of minimal residual disease in acute myeloid leukaemia by novel multiplex-PCR-based method. Leukemia. 18(12). 1981–1988. 21 indexed citations
15.
Nieuwenhuis, Eline J. C., C. René Leemans, Alain Kümmer, et al.. (2003). Assessment and Clinical Significance of Micrometastases in Lymph Nodes of Head and Neck Cancer Patients Detected by E48 (Ly-6D) Quantitative Reverse Transcription-Polymerase Chain Reaction. Laboratory Investigation. 83(8). 1233–1240. 59 indexed citations
16.
Nieuwenhuis, Eline J. C., Lies H. Jaspars, Jonas A. Castelijns, et al.. (2003). Quantitative molecular detection of minimal residual head and neck cancer in lymph node aspirates.. PubMed. 9(2). 755–61. 26 indexed citations
17.
Tabor, Maarten P., Michiel W. M. van den Brekel, J. Alain Kummer, et al.. (2002). Mutated p53 as a molecular marker for the diagnosis of head and neck cancer. The Journal of Pathology. 198(4). 476–486. 116 indexed citations
18.
Houten, Viola M. M. van, Peter J.F. Snijders, Michiel W. M. van den Brekel, et al.. (2001). Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas. International Journal of Cancer. 93(2). 232–235. 252 indexed citations
19.
Houten, Viola M. M. van, Michiel W. M. van den Brekel, Fedor Denkers, et al.. (2000). Molecular Diagnosis of Head and Neck Cancer. Recent results in cancer research. 157. 90–106. 15 indexed citations
20.
Denkers, Fedor, et al.. (1998). Labeling Efficiency of Oligonucleotides by T4 Polynucleotide Kinase Depends on 5′-Nucleotide. Analytical Biochemistry. 265(2). 386–389. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Serge Smeets Breakdown of academic impact, for papers by R Lilleng Breakdown of academic impact, for papers by Saman Abbas Breakdown of academic impact, for papers by Saara Kantola Breakdown of academic impact, for papers by Qiuliang Wu Breakdown of academic impact, for papers by K.R. Nalinakumari Breakdown of academic impact, for papers by Andre L. Reed Breakdown of academic impact, for papers by H Steininger Breakdown of academic impact, for papers by Nilva K. Cervigne Breakdown of academic impact, for papers by Jarrard Goodwin
Rankless by CCL
2026